
Rare Inherited EGFR Mutation Greatly Raises Lung Cancer Risk
People who inherit a rare change in the EGFR gene may be much more likely to develop lung cancer. Their risk is about 25 times

People who inherit a rare change in the EGFR gene may be much more likely to develop lung cancer. Their risk is about 25 times

Semaglutide 2.4 mg becomes Singapore’s first approved therapy for adults with noncirrhotic metabolic dysfunction-associated steatohepatitis and F2-F3 fibrosis. As reported on the Manila Times, Singapore’s

The Ebola Outbreak: DR Congo The Ebola outbreak in DR Congo was declared in May 2026. As reported by the BBC, it is now the

Patients in the United States wait an average of 34 to 50 days (roughly 1 to 1.5 months) for an initial neurology appointment, with wait

As reported on FiercePharma, Merck & Co.’s Welireg has secured an expanded FDA approval that moves the drug earlier in the treatment of advanced kidney

I thought I wanted a second baby. My son was an adult, and despite having an adorable Frenchie, I was ready to take steps to

15 years ago I released my first PKU project. I never imagined the day would come when I would need to assert my boundaries this

World Lung Day 2026 puts a spotlight on lung health across the life course Lung health begins early in life and needs to remain a

As reported on News Medical, researchers are increasingly exploring laboratory-grown organoids as potential tools for repairing damage caused by spinal cord and peripheral nerve injuries.

Twenty-six Novel Therapies have been FDA-approved so far this year. Medical journals, including “The Lancet”, see this as a difficult task. The Agency must maintain

As reported on PR Newswire, the U.S. Food and Drug Administration has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), introducing a once-weekly basal

Chronic diseases perplex doctors, while leaving patients mysteriously ill Meghan O’Rourke, the author of the best-selling book Invisible Kingdom, recently released an excerpt from this

As reported on MedPage Today, an experimental immunotherapy called gotistobart helped patients with advanced squamous non-small cell lung cancer (NSCLC) live longer than standard chemotherapy

Editor’s Note: Patient Worthy is honored to share this essay from Carrie Ostrea. I have been fortunate to share my rare disease daughter’s story for

A Q&A with Robert Groysman, MD, on why standard tests can miss long COVID—and how individualized care may help patients break the cycle When the

The Wall Street Journal opinion editors recently published an article a liquid biopsy test called Galleri, prior to an upcoming FDA review. Key Trial Results

For most of my life, I knew something was wrong with my body. I just never had a name for it. When I was around

“For people living with a progressive rare disease, time is measured differently. Research and clinical trials can take years while patients continue to lose strength
Have you been diagnosed with myelofibrosis and experienced anemia?
We’re looking to connect with people who are willing to share their experiences—from diagnosis and treatment to the everyday realities of living with myelofibrosis and anemia.
Your story could help another patient feel seen, understood, and less alone.
Interested in sharing your story? We’d love to hear from you. Click here: ow.ly/urtm50ZT9Ms or the link in our bio to get involved!
#Myelofibrosis #Anemia #PatientStories #PatientVoice #ShareYourStory #PatientWorthy
... See MoreSee Less

✨Living with a chronic illness can be frustrating when progress doesn't happen as quickly as you'd like. But healing, coping, and adapting are rarely straight lines.
The fact that you're still showing up each day says more than you realize.
#PatientWorthy #PatientCommunity #RareDiseaseCommunity #PatientVoices #HopeAndResilience
... See MoreSee Less

Living with myelofibrosis can mean navigating more than the disease itself. Complications like anemia can add another layer to a person’s experience and may influence how they feel from day to day.
Greater awareness can help patients and their loved ones better understand the challenges that may come with MF and encourage more informed conversations about care.
To learn more, click here: ow.ly/97ri50ZSRUe or the link in our bio!
#Myelofibrosis #Anemia #BloodCancer #MPN #RareDisease #ShareYourStory #PatientWorthy
... See MoreSee Less


+2
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.